ATE373093T1 - Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika - Google Patents

Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika

Info

Publication number
ATE373093T1
ATE373093T1 AT94915550T AT94915550T ATE373093T1 AT E373093 T1 ATE373093 T1 AT E373093T1 AT 94915550 T AT94915550 T AT 94915550T AT 94915550 T AT94915550 T AT 94915550T AT E373093 T1 ATE373093 T1 AT E373093T1
Authority
AT
Austria
Prior art keywords
sequences
diagnostics
hepatitis
medicinal products
present
Prior art date
Application number
AT94915550T
Other languages
English (en)
Inventor
Geert Maertens
Lieven Stuyver
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE373093T1 publication Critical patent/ATE373093T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94915550T 1993-04-27 1994-04-27 Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika ATE373093T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93401099 1993-04-27
EP93402019 1993-08-05

Publications (1)

Publication Number Publication Date
ATE373093T1 true ATE373093T1 (de) 2007-09-15

Family

ID=26134679

Family Applications (4)

Application Number Title Priority Date Filing Date
AT99118784T ATE551423T1 (de) 1993-04-27 1994-04-27 Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
AT94915550T ATE373093T1 (de) 1993-04-27 1994-04-27 Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika
AT99118785T ATE552340T1 (de) 1993-04-27 1994-04-27 Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
AT99118783T ATE553201T1 (de) 1993-04-27 1994-04-27 Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99118784T ATE551423T1 (de) 1993-04-27 1994-04-27 Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT99118785T ATE552340T1 (de) 1993-04-27 1994-04-27 Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
AT99118783T ATE553201T1 (de) 1993-04-27 1994-04-27 Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel

Country Status (15)

Country Link
US (3) US7157226B1 (de)
EP (4) EP0984067B1 (de)
JP (5) JPH07508423A (de)
CN (1) CN1108030A (de)
AT (4) ATE551423T1 (de)
AU (1) AU688323B2 (de)
BR (1) BR9405334A (de)
CA (2) CA2139100C (de)
DE (1) DE69435023T2 (de)
ES (1) ES2294779T3 (de)
FI (1) FI946066A (de)
NO (1) NO944967D0 (de)
NZ (1) NZ266148A (de)
SG (1) SG50563A1 (de)
WO (1) WO1994025601A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123875C (en) 1991-11-21 2005-05-24 Peter Simmons Hepatitis-c virus testing
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US7258977B1 (en) * 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
EP0984067B1 (de) 1993-04-27 2012-04-04 Innogenetics N.V. Hepatitis C Virus Genotypsequenzen sowie ihre Verwendung als Behandlungs- und Nachweismitteln
US7255997B1 (en) * 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
ES2231773T3 (es) 1993-05-05 2005-05-16 Common Services Agency Virus de la hepatitis c de tipo 4, 5 y 6.
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE69526973T3 (de) * 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
WO1998012332A1 (en) * 1996-09-17 1998-03-26 Chiron Corporation Compositions and methods for treating intracellular diseases
ES2310701T3 (es) 1998-04-17 2009-01-16 Innogenetics N.V. Metodos para mejorar la conformacion de proteinas por medio de agentes reductores.
WO1999055385A2 (de) * 1998-04-28 1999-11-04 Wolfgang Bergter Radioimmunpharmaka zur therapie der hepatitis c
US7052830B1 (en) 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
DE69934810T2 (de) * 1998-06-09 2007-10-11 Branch, Andrea D. Neues hepatitis c viruspeptid und seine verwendung
ES2277932T5 (es) 2000-06-15 2010-06-28 Novartis Vaccines And Diagnostics, Inc. Ensayo de combinacion de antigeno/anticuerpo del vhc.
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
AU2001290178A1 (en) * 2000-08-17 2002-02-25 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
MD2149G2 (ro) * 2001-11-23 2003-10-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
DK1947104T3 (da) * 2002-03-11 2012-08-06 Lab 21 Ltd Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C
US7528223B2 (en) 2002-07-24 2009-05-05 Intercell Ag Antigens encoded by alternative reading frames from pathogenic viruses
JP2006504687A (ja) 2002-09-13 2006-02-09 インターツェル・アクチェンゲゼルシャフト Ｃ型肝炎ウイルスペプチドの単離方法
EP1608402B1 (de) 2003-03-24 2010-10-20 Intercell AG Verbesserte impfstoffe
PL1648502T3 (pl) 2003-07-11 2011-05-31 Intercell Ag Szczepionki przeciwko HCV
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
WO2005067643A2 (en) 2004-01-07 2005-07-28 Third Wave Technologies, Inc. Determination of hepatitis c virus genotype
US20060162667A1 (en) * 2005-01-26 2006-07-27 Papadoyianis Ernest D Aquatic habitat and ecological tank
EP1888751A2 (de) * 2005-05-25 2008-02-20 Tripep Ab Nichtstrukturelles ns3/4a-fusionsgen des hepatitis-c-virus
US7919242B2 (en) 2005-06-30 2011-04-05 Roche Molecular Systems, Inc. Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
MD3300G2 (ro) * 2006-09-28 2007-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
EP2121990A2 (de) * 2006-10-20 2009-11-25 Innogenetics N.V. Methodik zur analyse von sequenzvariationen innerhalb des hcv-ns5b-genombereichs
US20110136678A1 (en) 2006-10-20 2011-06-09 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
US20090325145A1 (en) 2006-10-20 2009-12-31 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns5b genomic region
US20100227314A1 (en) * 2007-08-09 2010-09-09 Dmitry Alexandrovich Gryadunov Method of identification of genotype and subtype of hepatitis c virus on a biological microchip
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
EP2215271A2 (de) * 2007-10-30 2010-08-11 Intermune, Inc. Hcv-genotypisierung und -phänotypisierung
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
CN102378914B (zh) * 2009-03-30 2014-12-10 生物梅里埃公司 用于hcv检测的固体支持物
WO2013150450A1 (en) * 2012-04-02 2013-10-10 Universidade Do Porto Hcv homolog fragments, cell-lines and applications thereof
RU2017133463A (ru) * 2015-03-27 2019-04-29 Орто-Клиникал Дайэгностикс, Инк. ПОЛИПЕПТИДЫ NS4a/МОДИФИЦИРОВАННЫЕ NS3 HCV И ИХ ПРИМЕНЕНИЕ
EP3494227A1 (de) * 2016-08-02 2019-06-12 Roche Diagnostics GmbH Helfer-oligonukleotid zur verbesserung der effizienz der amplifikation und detektion/quantifizierung von nukleinsäuren

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074422C (zh) * 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
GB2236819B (en) * 1989-09-14 1993-07-14 Gen Motors France Dual master cylinder
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
JP3156200B2 (ja) * 1989-09-15 2001-04-16 国立予防衛生研究所長 新規のｈｃｖ分離株
HUT56883A (en) 1989-12-18 1991-10-28 Wellcome Found Process for producing virus polypeptides
EP0435229A1 (de) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNS-Gen von einem Non-A Non-B Hepatitis-Virus, seine Klonierung und Verwendung
WO1991014779A1 (en) * 1990-03-28 1991-10-03 Mitsui Toatsu Chemicals, Incorporated Diagnostic for hepatitis virus
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
AU652941B2 (en) 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
DK0489968T3 (da) 1990-12-14 1997-03-24 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
EP0510952A1 (de) * 1991-04-26 1992-10-28 Immuno Japan Inc. Oligonukleotid-Primer und ihre Anwendung zum Nachweis von Non-A, Non-B-Hepatitis mit höchster Genauigkeit
ES2207633T3 (es) 1991-05-08 2004-06-01 Chiron Corporation Secuencias genomicas del vhc para diagnostico y tratamiento.
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Polypeptide des hepatitis c-virus (hiv)
EP0532167A3 (en) * 1991-08-09 1993-03-31 Immuno Japan Inc. Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
JPH06510191A (ja) * 1991-08-21 1994-11-17 アボツト・ラボラトリーズ Ｎｓ１に対する組換え抗原を利用したｃ型肝炎アッセイ
HU227510B1 (en) * 1991-09-13 2011-07-28 Novartis Vaccines & Diagnostic Immunoreactive hepatitis c virus polypeptide compositions
CA2123875C (en) * 1991-11-21 2005-05-24 Peter Simmons Hepatitis-c virus testing
DE69334357D1 (de) 1992-11-27 2011-06-09 Innogenetics Nv Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
EP0984067B1 (de) 1993-04-27 2012-04-04 Innogenetics N.V. Hepatitis C Virus Genotypsequenzen sowie ihre Verwendung als Behandlungs- und Nachweismitteln
SK282543B6 (sk) 1993-05-10 2002-10-08 Chiron Corporation Spôsob klasifikácie hepatitis C vírusu a činidlá na použitie pri tomto spôsobe
JPH06319563A (ja) 1993-05-13 1994-11-22 Imuno Japan:Kk Ｃ型肝炎ウイルス遺伝子、オリゴヌクレオチド、並びにｃ型 肝炎ウイルス遺伝子型判定方法
US5514539A (en) 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5882852A (en) 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
JP2687852B2 (ja) * 1993-10-13 1997-12-08 日本電気株式会社 半導体メモリ装置

Also Published As

Publication number Publication date
EP0651807B1 (de) 2007-09-12
CN1108030A (zh) 1995-09-06
NZ266148A (en) 1997-06-24
ATE552340T1 (de) 2012-04-15
SG50563A1 (en) 1998-07-20
CA2139100A1 (en) 1994-11-10
ATE553201T1 (de) 2012-04-15
JP2004041207A (ja) 2004-02-12
EP1004670A3 (de) 2000-09-20
ATE551423T1 (de) 2012-04-15
BR9405334A (pt) 1999-05-25
US20030032005A1 (en) 2003-02-13
US20030008274A1 (en) 2003-01-09
EP0984068B1 (de) 2012-03-28
US7195765B2 (en) 2007-03-27
EP1004670B1 (de) 2012-04-11
CA2139100C (en) 2009-06-23
ES2294779T3 (es) 2008-04-01
US6762024B2 (en) 2004-07-13
EP0984067B1 (de) 2012-04-04
AU6722294A (en) 1994-11-21
EP0984068A2 (de) 2000-03-08
US7157226B1 (en) 2007-01-02
JP2002233389A (ja) 2002-08-20
EP0984067A3 (de) 2000-09-27
EP1004670A2 (de) 2000-05-31
WO1994025601A2 (en) 1994-11-10
FI946066A0 (fi) 1994-12-23
AU688323B2 (en) 1998-03-12
JP2002233388A (ja) 2002-08-20
WO1994025601A3 (en) 1995-03-02
NO944967L (no) 1994-12-21
DE69435023D1 (de) 2007-10-25
NO944967D0 (no) 1994-12-21
DE69435023T2 (de) 2008-09-11
EP0984067A2 (de) 2000-03-08
JP2004041206A (ja) 2004-02-12
CA2662090A1 (en) 1994-11-10
JPH07508423A (ja) 1995-09-21
EP0651807A1 (de) 1995-05-10
EP0984068A3 (de) 2000-09-20
FI946066A (fi) 1994-12-23

Similar Documents

Publication Publication Date Title
ATE373093T1 (de) Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika
DK0637342T3 (da) Fremgangsmåde til typebestemmelse af HCV-isolater
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
WO1992019743A3 (en) Hcv genomic sequences for diagnostics and therapeutics
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
ATE206717T1 (de) Hcv-spezifische peptide, mittel dazu und ihre verwendung
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DK0489968T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE69232906T2 (de) Detektion des Hepatis-C Virus.
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
DE69125066D1 (de) cDNS-Sequenz und Detektion des Hepatitis C-Virus
IT1270941B (it) Peptidi di hcv e loro usi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0651807

Country of ref document: EP